Table 5.
ITT analysis (n = 182; total anatomical locations [437]) | ||||||
---|---|---|---|---|---|---|
All locations | Sacrum | Heel | ||||
SA+ | SA− | SA+ | SA− | SA+ | SA− | |
SEM Δ ≥ 0.6 | 42 | 261 | 13 | 61 | 29 | 200 |
SEMΔ < 0.6 | 6 | 128 | 3 | 41 | 3 | 87 |
Sensitivity | 87.5% (74.8%‐95.3%) | 81.3% (54.4%‐96.0%) | 90.6% (75.0%‐98.0%) | |||
Specificity | 32.9% (28.3%‐37.8%) | 40.2% (30.6%‐50.4%) | 30.3% (25.1%‐36.0%) | |||
Bootstrap sensitivity (all locations) 87.4% (95% CI: 77.8%–96.7%) | ||||||
Bootstrap specificity (all locations) 33% (95% CI: 27.6%–38.7%) | ||||||
ROCAUC 0.6713 (CI: 0.5969, 0.7457); P < .0001 | ||||||
Positive Predictive value (PPV) 14% (42/42 + 261) | ||||||
Negative predictive value (NPV) 96% (128/6 + 128) | ||||||
Per‐protocol analysis (n = 170) | ||||||
All locations | Sacrum | Heel | ||||
SA+ | SA− | SA+ | SA− | SA+ | SA− | |
SEM Δ ≥ 0.6 | 32 | 161 | 8 | 28 | 24 | 133 |
SEMΔ<0.6 | 6 | 79 | 3 | 20 | 3 | 59 |
Sensitivity | 84.2% (68.8%‐94.0%) | 72.7% (39.0%‐94.0%) | 88.9% (70.8%‐97.7%) | |||
Specificity | 32.9% (27.0%‐39.3%) | 41.7% (27.6%‐56.8%) | 30.7% (24.3%‐37.8%) |
Note: Matrix of true and false positive and negative diagnoses of pressure injury by the device (SEM) and the reference standard, clinical STA. A true positive is SA+/SEM+. A true negative is SA−/SEM−. A false positive is SA−/SEM+. A false negative is SA+/SEM−. Sensitivity and specificity are expressed as percentages with 95% confidence intervals; SA Δ ≥ 0.6 designates a positive diagnosis of pressure injury by skin and tissue assessment; SA Δ < 0.6 designates a negative diagnosis of pressure injury by skin and tissue assessment; SEM Δ ≥ 0.6 designates a positive diagnosis of pressure injury by the device; SEM Δ < 0.6 designates a negative diagnosis of pressure injury by the device.
Abbreviations: SEM, subepidermal moisture; STA, skin and tissue assessment; ITT, intent‐to‐treat.